日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Clinical Context Shapes the Relationship between Genomic Alterations and Response to AR Inhibitors and Chemotherapy in Metastatic Prostate Cancer.

临床背景决定了转移性前列腺癌中基因组改变与 AR 抑制剂和化疗反应之间的关系

Shah Kalpit, Secrest Matthew H, Zhou Wei, Wang Shu, Canter Dan, Zhang Yuxiang, Jin Dexter, Sokol Ethan, Nowicka Malgorzata, Ang Houle Armande, Metcalfe Ciara, Gendreau Steven, Schröder Carsten, Wongchenko Matthew, Attard Gerhardt

SPEX: A modular end-to-end platform for high-plex tissue spatial omics analysis.

SPEX:用于高通量组织空间组学分析的模块化端到端平台

Li Xiao, Pechuan-Jorge Ximo, Risom Tyler, Foo Conrad, Prilipko Alexander, Zubkov Artem, Chan Caleb, Chang Patrick, Peale Frank, Ziai James, Rost Sandra, Hibar Derrek, McGinnis Lisa, Tabatsky Evgeniy, Ye Xin, Bravo Hector Corrada, Shi Zhen, Nowicka Malgorzata, Scherdin Jon, Cowan James, Giltnane Jennifer, Orlova Darya, Jesudason Rajiv

UGT1A4 Polymorphism is not Associated with a Clinically Relevant Change in Giredestrant Exposure

UGT1A4 多态性与吉瑞地司他暴露量的临床相关变化无关

Malhi, Vikram; Nowicka, Malgorzata; Chen, Ya-Chi; Agarwal, Priya; Waldvogel, Marie; Lien, Yi Ting Kayla; Hafner, Marc; Perez-Moreno, Pablo; Moore, Heather M; Yu, Jiajie

Biomarker Data from the Phase III KATHERINE Study of Adjuvant T-DM1 versus Trastuzumab for Residual Invasive Disease after Neoadjuvant Therapy for HER2-Positive Breast Cancer

来自 III 期 KATHERINE 研究的生物标志物数据:辅助 T-DM1 与曲妥珠单抗治疗 HER2 阳性乳腺癌新辅助治疗后残留浸润性疾病的疗效比较

Denkert, Carsten; Lambertini, Chiara; Fasching, Peter A; Pogue-Geile, Katherine L; Mano, Max S; Untch, Michael; Wolmark, Norman; Huang, Chiun-Sheng; Loibl, Sibylle; Mamounas, Eleftherios P; Geyer, Charles E; Lucas, Peter C; Boulet, Thomas; Song, Chunyan; Lewis, Gail D; Nowicka, Malgorzata; de Haas, Sanne; Basik, Mark

Functional Mapping of AKT Signaling and Biomarkers of Response from the FAIRLANE Trial of Neoadjuvant Ipatasertib plus Paclitaxel for Triple-Negative Breast Cancer

FAIRLANE试验中新辅助伊帕他替尼联合紫杉醇治疗三阴性乳腺癌的AKT信号通路功能图谱及疗效生物标志物

Shi, Zhen; Wulfkuhle, Julia; Nowicka, Malgorzata; Gallagher, Rosa I; Saura, Cristina; Nuciforo, Paolo G; Calvo, Isabel; Andersen, Jay; Passos-Coelho, José Luis; Gil-Gil, Miguel J; Bermejo, Begoña; Pratt, Debra A; Ciruelos, Eva M; Villagrasa, Patricia; Wongchenko, Matthew J; Petricoin, Emanuel F; Oliveira, Mafalda; Isakoff, Steven J

Circulating Cell-free DNA as a Prognostic Biomarker in Patients with Advanced ALK+ Non-small Cell Lung Cancer in the Global Phase III ALEX Trial

循环游离DNA作为晚期ALK+非小细胞肺癌患者的预后生物标志物:全球III期ALEX试验

Dziadziuszko, Rafal; Peters, Solange; Mok, Tony; Camidge, D Ross; Gadgeel, Shirish M; Ou, Sai-Hong Ignatius; Konopa, Krzysztof; Noé, Johannes; Nowicka, Malgorzata; Bordogna, Walter; Morcos, Peter N; Smoljanovic, Vlatka; Shaw, Alice T

Prognostic significance of FCGR2B expression for the response of DLBCL patients to rituximab or obinutuzumab treatment

FCGR2B表达对弥漫性大B细胞淋巴瘤患者利妥昔单抗或奥妥珠单抗治疗反应的预后意义

Nowicka, Malgorzata; Hilton, Laura K; Ashton-Key, Margaret; Hargreaves, Chantal E; Lee, Chern; Foxall, Russell; Carter, Matthew J; Beers, Stephen A; Potter, Kathleen N; Bolen, Christopher R; Klein, Christian; Knapp, Andrea; Mir, Farheen; Rose-Zerilli, Matthew; Burton, Cathy; Klapper, Wolfram; Scott, David W; Sehn, Laurie H; Vitolo, Umberto; Martelli, Maurizio; Trneny, Marek; Rushton, Christopher K; Slack, Graham W; Farinha, Pedro; Strefford, Jonathan C; Oestergaard, Mikkel Z; Morin, Ryan D; Cragg, Mark S

Single-nucleotide Fcγ receptor polymorphisms do not impact obinutuzumab/rituximab outcome in patients with lymphoma

单核苷酸Fcγ受体多态性不影响奥妥珠单抗/利妥昔单抗治疗淋巴瘤患者的疗效。

Strefford, Jonathan C; Nowicka, Malgorzata; Hargreaves, Chantal E; Burton, Cathy; Davies, Andrew; Ganderton, Rosalind; Hiddemann, Wolfgang; Iriyama, Chisako; Klapper, Wolfram; Latham, Kate V; Martelli, Maurizio; Mir, Farheen; Parker, Helen; Potter, Kathleen N; Rose-Zerilli, Matthew J J; Sehn, Laurie H; Trněný, Marek; Vitolo, Umberto; Bolen, Christopher R; Klein, Christian; Knapp, Andrea; Oestergaard, Mikkel Z; Cragg, Mark S

diffcyt: Differential discovery in high-dimensional cytometry via high-resolution clustering

diffcyt:通过高分辨率聚类在高维细胞计数中实现差异性发现

Weber, Lukas M; Nowicka, Malgorzata; Soneson, Charlotte; Robinson, Mark D

DRIMSeq: a Dirichlet-multinomial framework for multivariate count outcomes in genomics

DRIMSeq:一种用于基因组学中多变量计数结果的狄利克雷-多项式框架

Nowicka, Malgorzata; Robinson, Mark D